Creative Medical Technology Holdings, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.73 | -$0.73 | -$0.73 |
Q2 2024 | 0 | -$0.84 | -$0.84 | -$0.84 |
Q3 2024 | 1 | -$0.85 | -$0.85 | -$0.85 |
Q4 2024 | 0 | -$0.87 | -$0.87 | -$0.87 |
Creative Medical Technology Holdings, Inc. Earnings Date And Information
Creative Medical Technology Holdings, Inc. last posted its earnings results on Friday, August 9th, 2024. The company reported $-1.11 earnings per share for the quarter, missing analysts' consensus estimates of $-0.84 by $0.27. The company had revenue of 8,000 for the quarter and had revenue of 9,000 for the year. Creative Medical Technology Holdings, Inc. has generated $-4 earnings per share over the last year ($-3.76 diluted earnings per share) and currently has a price-to-earnings ratio of -0.76. Creative Medical Technology Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Creative Medical Technology Holdings, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/09/2024 | Q2 2024 | -$0.84 | -$1.11 | -0.27 | $8,000 | $8,000 |
05/10/2024 | Q1 2024 | -$1.15 | -$0.73 | 0.42 | $0 | $0 |
04/29/2024 | Q4 2023 | -$1.21 | $3,000 | $3,000 | ||
11/14/2023 | Q3 2023 | -$0.86 | -$1.02 | -0.16 | $6,000 | $6,000 |
08/11/2023 | Q2 2023 | -$0.83 | -$0.78 | 0.05 | $15,000 | $0 |
05/12/2023 | Q1 2023 | -$1.00 | -$0.70 | 0.3 | $0 | |
05/01/2023 | Q4 2022 | -$4.37 | $18,600 | |||
11/10/2022 | Q3 2022 | -$0.13 | -$0.70 | -0.57 | $110,000 | $55,000 |
08/12/2022 | Q2 2022 | -$0.15 | -$2.25 | -2.1 | $10,000 | |
05/13/2022 | Q1 2022 | -$1.79 | $15,000 | |||
03/30/2022 | Q4 2021 | -$0.23 | -$11.13 | -10.9 | $67,754 | |
11/15/2021 | Q3 2021 | -$7.52 | $10,000 | |||
08/16/2021 | Q2 2021 | -$12.52 | $10,000 | |||
05/17/2021 | Q1 2021 | $122.20 | $0 | |||
03/17/2021 | Q4 2020 | -$251.26 | $17,500 | |||
11/13/2020 | Q3 2020 | $5.80 | $77,000 | |||
08/14/2020 | Q2 2020 | -$54.46 | $27,900 | |||
05/15/2020 | Q1 2020 | $450.00 | $42,100 | |||
04/06/2020 | Q4 2019 | -$1,154.54 | $-4,400 | |||
11/14/2019 | Q3 2019 | -$1,194.11 | $57,500 |
Creative Medical Technology Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Creative Medical Technology Holdings, Inc.'s earnings date?
Creative Medical Technology Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
How can I listen to Creative Medical Technology Holdings, Inc.'s earnings conference call?
The conference call for Creative Medical Technology Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Creative Medical Technology Holdings, Inc.'s conference call transcript?
The conference call transcript for Creative Medical Technology Holdings, Inc.'s latest earnings report can be read online.
-
How much revenue does Creative Medical Technology Holdings, Inc. generate each year?
Creative Medical Technology Holdings, Inc. (:CELZ) has a recorded annual revenue of $9,000.
-
How much profit does Creative Medical Technology Holdings, Inc. generate each year?
Creative Medical Technology Holdings, Inc. (:CELZ) has a recorded net income of $9,000. Creative Medical Technology Holdings, Inc. has generated $-3.76 earnings per share over the last four quarters.
-
What is Creative Medical Technology Holdings, Inc.'s price-to-earnings ratio?
Creative Medical Technology Holdings, Inc. (:CELZ) has a price-to-earnings ratio of -0.76 and price/earnings-to-growth ratio is -0.01.